Accessing CPhM’s Annual Mandatory Professional Development Modules
As part of your professional requirements, pharmacists and pharmacy technicians must complete an annual mandatory professional development (PD) module on a new topic each year, which is required for license or listing renewal.
How to Access and Complete the Mandatory Modules:
- Log into the new Registrant Portal: Ensure you’ve logged into the new portal.
- Check the ‘Announcements’ section: Once you’re logged in, navigate to your homepage. Look for the ‘Announcements’ section, where CPhM posts important news and updates.
- Find the PD Modules Announcement: Within the ‘Announcements’ section, you will see an announcement titled Annual Mandatory Professional Development (PD) Modules. This contains essential details for accessing and completing the mandatory modules for the year 2023-2024.
- Access the Modules: To complete the following two mandatory modules: “Health Equity and Cultural Humility: An Introduction for Health Professionals in Manitoba” and “Pause Before You Post: Social Media Awareness”, you will need to enter a username and password. The link to the modules and login details can be found in the document within the “Announcements” section of your new registrant homepage.
Important notes to help you stay compliant:
- Proof of completion: Keep evidence of module completion for at least three years. You may need to submit this for regulatory review.
- Logging online: You must log your completed modules online. These will count as accredited learning in the PD year of completion.
- New pharmacy professionals: If you are new to the pharmacy profession, you are also required to complete the current year’s module, along with the previous mandatory PD modules.
We hope this guide helps you complete your mandatory PD modules with ease. If you have any questions or need assistance, please email email@example.com.
Your commitment to ongoing professional development is greatly appreciated.
ISMP Alert: Clonidine Compounding Errors Continue to Harm Children
ISMP recently published an article discussing the compounding of clonidine suspension for pediatric patients when commercially available formulations are not accessible. Compounding this medication is a high-risk process, and recent incidents have highlighted the potential for errors, emphasizing the need for enhanced safety measures and education in compounding. Two case examples are provided, one involving a dosage mix-up due to unit-of-measure confusion and another resulting from inaccurate trituration of clonidine powder.
The article also outlines the lack of a commercially available pediatric formulation for clonidine in Canada, which has led to the need for compounding. Clonidine has various off-label uses in children, but therapeutic doses can be smaller than available tablet strengths, necessitating compounding.
The recommendations in the article aim to reduce compounding errors and associated risks when preparing clonidine suspensions for pediatric patients. These recommendations involve pharmaceutical manufacturers, prescribers, pharmacy professionals, and others in the medication supply chain. Emphasizing the use of clonidine tablets for compounding and improved safety procedures are central to the suggested strategies.
For the full article, please click here: Clonidine Compounding Safety Bulletin.
Upcoming Professional Development Opportunity: Lessons from Complaints: A Series on Injection-Related Best Practices
Mark your calendars for an upcoming two-part professional development learning activity titled Lessons from Complaints: A Series on Injection-Related Best Practices, hosted by the College of Pharmacists of Manitoba (CPhM).
The recordings will be available on November 1, 2023, and you can access them on the Accredited Learning Activities page under the Recorded PD Programs section on the CPhM website or within future Friday Five editions in the “Upcoming Events & Professional Development” section below.
The CPhM Complaints Committee strongly recommends viewing both recordings, as each presentation offers specific learning objectives aimed at refreshing injection-certified pharmacists on best practices and addressing common concerns brought to the Complaints Committee. Please see below for the learning objectives of each recording:
PART 1: Best Practices Review for Pharmacists
- Explain the significance and demonstrate the steps involved in aseptic technique.
- Identify and describe potential injuries, such as Shoulder Injury Related to Vaccine Administration (SIRVA), resulting from improper injection technique and administration.
- Describe and demonstrate the proper landmarking and technique for intramuscular and subcutaneous injections.
- List the seven rights of medication administration.
Part 2: Trends in Injection-Related Complaints
- Summarize the training requirements for obtaining and maintaining injection authorization.
- Identify and apply key components of the Practice Direction: Administration of Drugs, including Vaccines, which are frequently overlooked in practice, leading to complaint matters or unsafe care.
- Explain the documentation and record-keeping requirements associated with drug or vaccine administration by injection.
- Describe medication incident reporting procedures related to drug or vaccine administration by injection.
- Implement essential strategies for effectively managing injection-related errors or complaints.
SIQ Feature: Safeguarding Pharmacy Technology: 4 Safety Recommendations for Bar Coding
A recent blog post from Safety IQ Academy discusses the critical role of bar code scanning in pharmacy practice to enhance medication safety. Bar code scanning technology is employed to verify the accuracy of medication selection, ensuring that the proper medication, strength, and dosage are dispensed to patients. While this technology significantly reduces the chances of medication incidents, the article highlights instances where workarounds and cognitive biases can compromise its effectiveness.
Some key points from the article include:
- The importance of bar code scanning technology in reducing medication incidents.
- A real-life incident example showcasing how errors can occur despite bar code scanning.
- Concerns related to workarounds and cognitive bias compromising medication safety.
Pharmacy professionals are reminded to stay vigilant, address workarounds, and raise awareness of cognitive biases to ensure medication safety and maintain the quality of patient care. For the full article, click here: Safeguarding Pharmacy Technology: 4 Safety Recommendations for Bar Coding
Upcoming Events & Professional Development Opportunities
Canadian Association of Pharmacy Technicians (CAPT) VIRTUAL National Conference
November 12, 2023, at 11:30 EST
Click here to register and for more information.
Targeting Social Isolation Together E-Modules
CCCEP accredited for 2.0 CEUs
Click here to sign up and for more information.
Managing Drug Shortages in Pediatric Patients
Can be claimed as 0.75 accredited CEUs
Click here to view the recording.